Drugs Made In America Acquisition Corp. Units Capital Reinvestment Ratio

Latest as of September 2025: 0.00x

Drugs Made In America Acquisition Corp. Units capital reinvestment ratio. Drugs Made In America Acquisition Corp. Units (DMAAU) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($137.91K) in capital expenditures ($4.00). Check DMAAU cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$137.91K

USD

Capital Expenditures

$4.00

USD

Data as of

Sep 2025

Most recent filing

Drugs Made In America Acquisition Corp. Units Capital Reinvestment Ratio by Year (None–None)

Drugs Made In America Acquisition Corp. Units capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see cash flow conversion of Drugs Made In America Acquisition Corp. .

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow